Back to today’s briefing

Story perspectives

Patients Face NHS GLP-1 Injection Shortages, Pay Privately

9/25/2025

49 6 Full Breakdown

Summary

Story summary

In North Tyneside, patients struggle to access National Health Service (NHS) GLP-1 injections, forcing many to pay privately up to £200 monthly.
In June, 400,000 GLP-1 prescriptions were issued nationwide, but the NHS lacks infrastructure to meet rising obesity-treatment demand.
The NHS rolls out weight-management services, including phased tirzepatide (Mounjaro) access for eligible patients, amid cost and GP workload concerns.

1 of 1

Story summary

In North Tyneside, patients struggle to access National Health Service (NHS) GLP-1 injections, forcing many to pay privately up to £200 monthly.
In June, 400,000 GLP-1 prescriptions were issued nationwide, but the NHS lacks infrastructure to meet rising obesity-treatment demand.
The NHS rolls out weight-management services, including phased tirzepatide (Mounjaro) access for eligible patients, amid cost and GP workload concerns.